Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) Stock Competitors & Peer Comparison
See LMRI's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LMRI and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LMRI | $10.26 | +1.13% | 985.8M | -19.96 | -$0.51 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.95 | -0.03% | 174.7B | 19.37 | $5.21 | +2.46% |
| MDT | $87.09 | -2.69% | 111.5B | 15.75 | $5.53 | +3.28% |
| SYK | $278.77 | +1.26% | 106.9B | 20.83 | $13.39 | +1.25% |
| BSX | $43.88 | -0.52% | 65.2B | 14.15 | $3.10 | N/A |
| EW | $88.08 | +1.44% | 50.7B | 32.63 | $2.70 | N/A |
| DXCM | $86.64 | -0.05% | 32.7B | 33.98 | $2.55 | N/A |
| GEHC | $66.46 | -0.48% | 30B | 14.57 | $4.56 | +0.21% |
| PHG | $24.77 | -1.35% | 24.2B | 14.15 | $1.75 | +4.02% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
LMRI vs BSX-PA Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, LMRI's ROE is -0.06%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, LMRI is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
LMRI vs ABT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ABT has a market cap of 174.7B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ABT trades at $100.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ABT's P/E ratio is 19.37. In terms of profitability, LMRI's ROE is -0.06%, compared to ABT's ROE of +0.11%. Regarding short-term risk, LMRI is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ABT's competition here
Medtronic plc (NYSE: MDT)
LMRI vs MDT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, MDT has a market cap of 111.5B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while MDT trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas MDT's P/E ratio is 15.75. In terms of profitability, LMRI's ROE is -0.06%, compared to MDT's ROE of +0.11%. Regarding short-term risk, LMRI is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
LMRI vs SYK Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SYK has a market cap of 106.9B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SYK trades at $278.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SYK's P/E ratio is 20.83. In terms of profitability, LMRI's ROE is -0.06%, compared to SYK's ROE of +0.16%. Regarding short-term risk, LMRI is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
LMRI vs BSX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BSX has a market cap of 65.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BSX trades at $43.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BSX's P/E ratio is 14.15. In terms of profitability, LMRI's ROE is -0.06%, compared to BSX's ROE of +0.15%. Regarding short-term risk, LMRI is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
LMRI vs EW Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, EW has a market cap of 50.7B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while EW trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas EW's P/E ratio is 32.63. In terms of profitability, LMRI's ROE is -0.06%, compared to EW's ROE of +0.10%. Regarding short-term risk, LMRI is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
LMRI vs DXCM Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, DXCM has a market cap of 32.7B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while DXCM trades at $86.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas DXCM's P/E ratio is 33.98. In terms of profitability, LMRI's ROE is -0.06%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, LMRI is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
LMRI vs GEHC Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, GEHC has a market cap of 30B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while GEHC trades at $66.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas GEHC's P/E ratio is 14.57. In terms of profitability, LMRI's ROE is -0.06%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, LMRI is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
LMRI vs PHG Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, PHG has a market cap of 24.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while PHG trades at $24.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas PHG's P/E ratio is 14.15. In terms of profitability, LMRI's ROE is -0.06%, compared to PHG's ROE of +0.10%. Regarding short-term risk, LMRI is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
LMRI vs ZBH Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ZBH has a market cap of 17.7B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ZBH trades at $91.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ZBH's P/E ratio is 10.77. In terms of profitability, LMRI's ROE is -0.06%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, LMRI is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
LMRI vs ABMD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ABMD's P/E ratio is 65.36. In terms of profitability, LMRI's ROE is -0.06%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, LMRI is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
LMRI vs SWAV Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SWAV's P/E ratio is 78.76. In terms of profitability, LMRI's ROE is -0.06%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, LMRI is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
LMRI vs PEN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while PEN trades at $318.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas PEN's P/E ratio is 83.26. In terms of profitability, LMRI's ROE is -0.06%, compared to PEN's ROE of +0.11%. Regarding short-term risk, LMRI is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
LMRI vs SNN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SNN trades at $26.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SNN's P/E ratio is 18.19. In terms of profitability, LMRI's ROE is -0.06%, compared to SNN's ROE of +0.12%. Regarding short-term risk, LMRI is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
LMRI vs BIO-B Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BIO-B has a market cap of 10.5B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BIO-B trades at $385.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BIO-B's P/E ratio is -67.89. In terms of profitability, LMRI's ROE is -0.06%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, LMRI is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
LMRI vs ALGN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ALGN has a market cap of 10.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ALGN trades at $144.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ALGN's P/E ratio is 13.13. In terms of profitability, LMRI's ROE is -0.06%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, LMRI is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
LMRI vs BIO Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BIO trades at $379.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BIO's P/E ratio is 40.90. In terms of profitability, LMRI's ROE is -0.06%, compared to BIO's ROE of +0.03%. Regarding short-term risk, LMRI is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check BIO's competition here
Globus Medical, Inc. (NYSE: GMED)
LMRI vs GMED Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, GMED has a market cap of 10.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while GMED trades at $75.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas GMED's P/E ratio is 17.06. In terms of profitability, LMRI's ROE is -0.06%, compared to GMED's ROE of +0.12%. Regarding short-term risk, LMRI is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
LMRI vs BRKR Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BRKR has a market cap of 9.8B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BRKR trades at $64.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BRKR's P/E ratio is 32.42. In terms of profitability, LMRI's ROE is -0.06%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, LMRI is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
LMRI vs BRKRP Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BRKRP has a market cap of 9.5B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BRKRP trades at $470.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BRKRP's P/E ratio is 256.72. In terms of profitability, LMRI's ROE is -0.06%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, LMRI is less volatile compared to BRKRP. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BRKRP's competition here
Masimo Corporation (NASDAQ: MASI)
LMRI vs MASI Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas MASI's P/E ratio is 44.43. In terms of profitability, LMRI's ROE is -0.06%, compared to MASI's ROE of +0.09%. Regarding short-term risk, LMRI is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
LMRI vs GKOS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, GKOS has a market cap of 9.4B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while GKOS trades at $158.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas GKOS's P/E ratio is -184.34. In terms of profitability, LMRI's ROE is -0.06%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, LMRI is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
LMRI vs PODD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, PODD has a market cap of 9.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while PODD trades at $132.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas PODD's P/E ratio is 22.63. In terms of profitability, LMRI's ROE is -0.06%, compared to PODD's ROE of +0.27%. Regarding short-term risk, LMRI is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check PODD's competition here
Haemonetics Corporation (NYSE: HAE)
LMRI vs HAE Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, HAE has a market cap of 4.8B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while HAE trades at $105.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas HAE's P/E ratio is 21.13. In terms of profitability, LMRI's ROE is -0.06%, compared to HAE's ROE of +0.11%. Regarding short-term risk, LMRI is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
LMRI vs NARI Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas NARI's P/E ratio is -59.24. In terms of profitability, LMRI's ROE is -0.06%, compared to NARI's ROE of -0.00%. Regarding short-term risk, LMRI is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
LMRI vs ITGR Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ITGR trades at $126.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ITGR's P/E ratio is 19.90. In terms of profitability, LMRI's ROE is -0.06%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, LMRI is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
LMRI vs LIVN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while LIVN trades at $76.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas LIVN's P/E ratio is 18.29. In terms of profitability, LMRI's ROE is -0.06%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, LMRI is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
LMRI vs IRTC Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while IRTC trades at $114.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas IRTC's P/E ratio is -265.63. In terms of profitability, LMRI's ROE is -0.06%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, LMRI is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
LMRI vs AXNX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas AXNX's P/E ratio is -709.80. In terms of profitability, LMRI's ROE is -0.06%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, LMRI is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
LMRI vs TMDX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while TMDX trades at $84.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas TMDX's P/E ratio is 42.68. In terms of profitability, LMRI's ROE is -0.06%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, LMRI is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
LMRI vs NEOG Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, NEOG has a market cap of 2.8B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while NEOG trades at $12.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas NEOG's P/E ratio is 45.46. In terms of profitability, LMRI's ROE is -0.06%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, LMRI is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check NEOG's competition here
Butterfly Network, Inc. (NYSE: BFLY)
LMRI vs BFLY Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BFLY trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BFLY's P/E ratio is -37.90. In terms of profitability, LMRI's ROE is -0.06%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, LMRI is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BFLY's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
LMRI vs UFPT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while UFPT trades at $296.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas UFPT's P/E ratio is 30.33. In terms of profitability, LMRI's ROE is -0.06%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, LMRI is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check UFPT's competition here
AxoGen, Inc. (NASDAQ: AXGN)
LMRI vs AXGN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, AXGN has a market cap of 2.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while AXGN trades at $42.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas AXGN's P/E ratio is 111.68. In terms of profitability, LMRI's ROE is -0.06%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, LMRI is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
LMRI vs INSP Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, INSP has a market cap of 2.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while INSP trades at $73.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas INSP's P/E ratio is 32.26. In terms of profitability, LMRI's ROE is -0.06%, compared to INSP's ROE of +0.18%. Regarding short-term risk, LMRI is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check INSP's competition here
NuVasive, Inc. (NASDAQ: NUVA)
LMRI vs NUVA Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas NUVA's P/E ratio is 75.00. In terms of profitability, LMRI's ROE is -0.06%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, LMRI is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
LMRI vs ESTA Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ESTA has a market cap of 1.9B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ESTA trades at $63.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ESTA's P/E ratio is -50.56. In terms of profitability, LMRI's ROE is -0.06%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, LMRI is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
LMRI vs NVCR Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while NVCR trades at $15.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas NVCR's P/E ratio is -12.30. In terms of profitability, LMRI's ROE is -0.06%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, LMRI is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
LMRI vs ATEC Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ATEC trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ATEC's P/E ratio is -172.83. In terms of profitability, LMRI's ROE is -0.06%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, LMRI is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
LMRI vs CNMD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CNMD trades at $46.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CNMD's P/E ratio is 10.26. In terms of profitability, LMRI's ROE is -0.06%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, LMRI is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
LMRI vs HSKA Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas HSKA's P/E ratio is -62.49. In terms of profitability, LMRI's ROE is -0.06%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, LMRI is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
LMRI vs IART Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while IART trades at $16.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas IART's P/E ratio is 7.05. In terms of profitability, LMRI's ROE is -0.06%, compared to IART's ROE of -0.01%. Regarding short-term risk, LMRI is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check IART's competition here
Avanos Medical, Inc. (NYSE: AVNS)
LMRI vs AVNS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas AVNS's P/E ratio is 27.77. In terms of profitability, LMRI's ROE is -0.06%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, LMRI is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check AVNS's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
LMRI vs TNDM Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while TNDM trades at $16.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas TNDM's P/E ratio is -17.82. In terms of profitability, LMRI's ROE is -0.06%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, LMRI is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
LMRI vs SILK Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SILK's P/E ratio is -18.96. In terms of profitability, LMRI's ROE is -0.06%, compared to SILK's ROE of -0.35%. Regarding short-term risk, LMRI is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check SILK's competition here
Artivion, Inc. (NYSE: AORT)
LMRI vs AORT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while AORT trades at $22.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas AORT's P/E ratio is 38.07. In terms of profitability, LMRI's ROE is -0.06%, compared to AORT's ROE of -0.01%. Regarding short-term risk, LMRI is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check AORT's competition here
IRadimed Corporation (NASDAQ: IRMD)
LMRI vs IRMD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while IRMD trades at $86.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas IRMD's P/E ratio is 43.45. In terms of profitability, LMRI's ROE is -0.06%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, LMRI is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
LMRI vs FNA Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas FNA's P/E ratio is -19.83. In terms of profitability, LMRI's ROE is -0.06%, compared to FNA's ROE of -0.35%. Regarding short-term risk, LMRI is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
LMRI vs ENOV Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ENOV trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ENOV's P/E ratio is 5.29. In terms of profitability, LMRI's ROE is -0.06%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, LMRI is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
LMRI vs PRCT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while PRCT trades at $18.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas PRCT's P/E ratio is -9.39. In terms of profitability, LMRI's ROE is -0.06%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, LMRI is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check PRCT's competition here
Bioventus Inc. (NASDAQ: BVS)
LMRI vs BVS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BVS has a market cap of 948.5M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BVS trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BVS's P/E ratio is 18.42. In terms of profitability, LMRI's ROE is -0.06%, compared to BVS's ROE of +0.28%. Regarding short-term risk, LMRI is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
LMRI vs CBLL Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CBLL has a market cap of 943.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CBLL trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CBLL's P/E ratio is -14.12. In terms of profitability, LMRI's ROE is -0.06%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, LMRI is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
LMRI vs BBNX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BBNX has a market cap of 873.2M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BBNX trades at $19.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BBNX's P/E ratio is -11.76. In terms of profitability, LMRI's ROE is -0.06%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, LMRI is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BBNX's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
LMRI vs SIBN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SIBN has a market cap of 849.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SIBN trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SIBN's P/E ratio is -56.32. In terms of profitability, LMRI's ROE is -0.06%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, LMRI is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check SIBN's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
LMRI vs CSII Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CSII's P/E ratio is -20.83. In terms of profitability, LMRI's ROE is -0.06%, compared to CSII's ROE of -0.14%. Regarding short-term risk, LMRI is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
LMRI vs INMD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, INMD has a market cap of 817.4M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while INMD trades at $14.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas INMD's P/E ratio is 9.88. In terms of profitability, LMRI's ROE is -0.06%, compared to INMD's ROE of +0.12%. Regarding short-term risk, LMRI is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check INMD's competition here
Varex Imaging Corporation (NASDAQ: VREX)
LMRI vs VREX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas VREX's P/E ratio is 19.44. In terms of profitability, LMRI's ROE is -0.06%, compared to VREX's ROE of +0.05%. Regarding short-term risk, LMRI is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
LMRI vs AHCO Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, AHCO has a market cap of 771.4M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while AHCO trades at $5.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas AHCO's P/E ratio is 11.57. In terms of profitability, LMRI's ROE is -0.06%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, LMRI is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check AHCO's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
LMRI vs CTKB Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CTKB has a market cap of 743.9M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CTKB trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CTKB's P/E ratio is -30.51. In terms of profitability, LMRI's ROE is -0.06%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, LMRI is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CTKB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
LMRI vs AVR Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, AVR has a market cap of 738M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while AVR trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas AVR's P/E ratio is -3.91. In terms of profitability, LMRI's ROE is -0.06%, compared to AVR's ROE of -0.78%. Regarding short-term risk, LMRI is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
LMRI vs SRDX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SRDX's P/E ratio is -34.66. In terms of profitability, LMRI's ROE is -0.06%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, LMRI is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check SRDX's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
LMRI vs KIDS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, KIDS has a market cap of 584.6M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while KIDS trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas KIDS's P/E ratio is -19.29. In terms of profitability, LMRI's ROE is -0.06%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, LMRI is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
LMRI vs APEN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas APEN's P/E ratio is -9.43. In terms of profitability, LMRI's ROE is -0.06%, compared to APEN's ROE of -0.85%. Regarding short-term risk, LMRI is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check APEN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
LMRI vs SSII Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SSII has a market cap of 578.4M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SSII trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SSII's P/E ratio is -48.17. In terms of profitability, LMRI's ROE is -0.06%, compared to SSII's ROE of -0.27%. Regarding short-term risk, LMRI is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check SSII's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
LMRI vs PACB Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, PACB has a market cap of 568.4M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while PACB trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas PACB's P/E ratio is -4.46. In terms of profitability, LMRI's ROE is -0.06%, compared to PACB's ROE of -49.62%. Regarding short-term risk, LMRI is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
LMRI vs DCTH Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, DCTH has a market cap of 547.2M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while DCTH trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas DCTH's P/E ratio is 1585.00. In terms of profitability, LMRI's ROE is -0.06%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, LMRI is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
LMRI vs ZIMV Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, LMRI's ROE is -0.06%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, LMRI is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ZIMV's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
LMRI vs SGHT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SGHT has a market cap of 508.7M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SGHT trades at $9.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SGHT's P/E ratio is -16.70. In terms of profitability, LMRI's ROE is -0.06%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, LMRI is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check SGHT's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
LMRI vs TCMD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, TCMD has a market cap of 508.2M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while TCMD trades at $22.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas TCMD's P/E ratio is 20.86. In terms of profitability, LMRI's ROE is -0.06%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, LMRI is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
LMRI vs CERS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CERS has a market cap of 497.8M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CERS trades at $2.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CERS's P/E ratio is -82.06. In terms of profitability, LMRI's ROE is -0.06%, compared to CERS's ROE of -0.10%. Regarding short-term risk, LMRI is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
LMRI vs NPCE Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, NPCE has a market cap of 475.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while NPCE trades at $13.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas NPCE's P/E ratio is -24.46. In terms of profitability, LMRI's ROE is -0.06%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, LMRI is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
LMRI vs SENS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SENS has a market cap of 420M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SENS trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SENS's P/E ratio is -4.51. In terms of profitability, LMRI's ROE is -0.06%, compared to SENS's ROE of -1.66%. Regarding short-term risk, LMRI is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
LMRI vs OFIX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, OFIX has a market cap of 394.1M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while OFIX trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas OFIX's P/E ratio is -6.35. In terms of profitability, LMRI's ROE is -0.06%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, LMRI is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
LMRI vs CLPT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CLPT has a market cap of 353M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CLPT trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CLPT's P/E ratio is -9.97. In terms of profitability, LMRI's ROE is -0.06%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, LMRI is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CLPT's competition here
CapsoVision, Inc. (NASDAQ: CV)
LMRI vs CV Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CV has a market cap of 334.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CV trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CV's P/E ratio is -10.62. In terms of profitability, LMRI's ROE is -0.06%, compared to CV's ROE of -1.78%. Regarding short-term risk, LMRI is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CV's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
LMRI vs SMLR Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas SMLR's P/E ratio is 3.92. In terms of profitability, LMRI's ROE is -0.06%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, LMRI is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
LMRI vs TMCI Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, TMCI has a market cap of 299.7M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while TMCI trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas TMCI's P/E ratio is -4.91. In terms of profitability, LMRI's ROE is -0.06%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, LMRI is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
LMRI vs CATX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, CATX has a market cap of 298.8M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while CATX trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas CATX's P/E ratio is -1.97. In terms of profitability, LMRI's ROE is -0.06%, compared to CATX's ROE of -0.42%. Regarding short-term risk, LMRI is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check CATX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
LMRI vs RCEL Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, RCEL has a market cap of 297.1M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while RCEL trades at $11.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas RCEL's P/E ratio is -8.31. In terms of profitability, LMRI's ROE is -0.06%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, LMRI is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check RCEL's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
LMRI vs INFU Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, INFU has a market cap of 263M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while INFU trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas INFU's P/E ratio is 31.78. In terms of profitability, LMRI's ROE is -0.06%, compared to INFU's ROE of +0.15%. Regarding short-term risk, LMRI is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check INFU's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
LMRI vs TLSI Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, TLSI has a market cap of 261.7M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while TLSI trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas TLSI's P/E ratio is -2.53. In terms of profitability, LMRI's ROE is -0.06%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, LMRI is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check TLSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
LMRI vs MGRM Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas MGRM's P/E ratio is -12.00. In terms of profitability, LMRI's ROE is -0.06%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, LMRI is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
LMRI vs ELMD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ELMD has a market cap of 232.9M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ELMD trades at $28.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ELMD's P/E ratio is 21.47. In terms of profitability, LMRI's ROE is -0.06%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, LMRI is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
LMRI vs NVRO Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas NVRO's P/E ratio is -1.91. In terms of profitability, LMRI's ROE is -0.06%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, LMRI is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check NVRO's competition here
Profound Medical Corp. (NASDAQ: PROF)
LMRI vs PROF Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, PROF has a market cap of 207.9M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while PROF trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas PROF's P/E ratio is -5.84. In terms of profitability, LMRI's ROE is -0.06%, compared to PROF's ROE of -0.56%. Regarding short-term risk, LMRI is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
LMRI vs RXST Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, RXST has a market cap of 197.5M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while RXST trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas RXST's P/E ratio is -4.22. In terms of profitability, LMRI's ROE is -0.06%, compared to RXST's ROE of -0.17%. Regarding short-term risk, LMRI is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
LMRI vs BSGM Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas BSGM's P/E ratio is -5.81. In terms of profitability, LMRI's ROE is -0.06%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, LMRI is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check BSGM's competition here
Quantum-Si incorporated (NASDAQ: QSI)
LMRI vs QSI Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, QSI has a market cap of 189.5M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while QSI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas QSI's P/E ratio is -2.08. In terms of profitability, LMRI's ROE is -0.06%, compared to QSI's ROE of -0.47%. Regarding short-term risk, LMRI is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check QSI's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
LMRI vs MDGS Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas MDGS's P/E ratio is -0.27. In terms of profitability, LMRI's ROE is -0.06%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, LMRI is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check MDGS's competition here
Quanterix Corporation (NASDAQ: QTRX)
LMRI vs QTRX Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, QTRX has a market cap of 172.9M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while QTRX trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas QTRX's P/E ratio is -1.44. In terms of profitability, LMRI's ROE is -0.06%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, LMRI is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
LMRI vs FOCL Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, FOCL has a market cap of 170.2M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while FOCL trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas FOCL's P/E ratio is -4.39. In terms of profitability, LMRI's ROE is -0.06%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, LMRI is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check FOCL's competition here
Neuronetics, Inc. (NASDAQ: STIM)
LMRI vs STIM Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, STIM has a market cap of 164.2M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while STIM trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas STIM's P/E ratio is -5.36. In terms of profitability, LMRI's ROE is -0.06%, compared to STIM's ROE of -1.51%. Regarding short-term risk, LMRI is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
LMRI vs QIPT Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas QIPT's P/E ratio is -15.87. In terms of profitability, LMRI's ROE is -0.06%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, LMRI is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check QIPT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
LMRI vs LUCD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, LUCD has a market cap of 154.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while LUCD trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas LUCD's P/E ratio is -2.19. In terms of profitability, LMRI's ROE is -0.06%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, LMRI is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check LUCD's competition here
Inogen, Inc. (NASDAQ: INGN)
LMRI vs INGN Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, INGN has a market cap of 145.4M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while INGN trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas INGN's P/E ratio is -5.90. In terms of profitability, LMRI's ROE is -0.06%, compared to INGN's ROE of -0.13%. Regarding short-term risk, LMRI is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check INGN's competition here
iCAD, Inc. (NASDAQ: ICAD)
LMRI vs ICAD Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ICAD's P/E ratio is -20.37. In terms of profitability, LMRI's ROE is -0.06%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, LMRI is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
LMRI vs HJLI Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas HJLI's P/E ratio is N/A. In terms of profitability, LMRI's ROE is -0.06%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, LMRI is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check HJLI's competition here
electroCore, Inc. (NASDAQ: ECOR)
LMRI vs ECOR Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ECOR has a market cap of 98.1M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ECOR trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ECOR's P/E ratio is -6.48. In terms of profitability, LMRI's ROE is -0.06%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, LMRI is less volatile compared to ECOR. This indicates lower risk in terms of short-term price fluctuations for LMRI.Check ECOR's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
LMRI vs ASXC Comparison September 2026
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LMRI stands at 985.8M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, LMRI is priced at $10.26 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LMRI currently has a P/E ratio of -19.96, whereas ASXC's P/E ratio is -1.12. In terms of profitability, LMRI's ROE is -0.06%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, LMRI is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for LMRI.Check ASXC's competition here